Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease

Summary

The purpose of this research study is to gather scientific information about the effectiveness and safety of the study drug, Ecopipam (PSYRX 101), for the treatment of self-injurious behaviors when compared with the effectiveness and safety of placebo (inactive substance) in subjects with Lesch-Nyhan Disease.

Timeline

Start

2012-12

Primary completion

2013-12

Completion

2014-12

Drugs

Indications